Top Markets
Coin of the day
Clearbridge Health Limited Clearbridge Health Limited

Clearbridge Health Limited

1H3
Peringkat dalam Saham #32405
Established in 2010 and headquartered in Singapore, Clearbridge Health Limited... Established in 2010 and headquartered in Singapore, Clearbridge Health Limited operates as an investment holding company, delivering diverse healthcare solutions globally, including in Singapore, the Philippines, Hong Kong, and Malaysia. The firm's activities are organized into three key divisions: Strategic Investments, Healthcare Systems, and Medical Clinics/Centres. Its extensive range of services encompasses advanced imaging diagnostics, such as general X-ray, CT scans (including dental cone beam), mammography, MRI, and ultrasound. Furthermore, Clearbridge offers general wellness screenings for conditions like diabetes, high blood pressure, and elevated cholesterol, alongside vaccination programs. Specialized care includes renal treatment, clinical services, aesthetic procedures, and dental and orthodontic services. Beyond patient care, the company provides consultancy to healthcare organizations and is involved in the wholesale supply of medicinal and pharmaceutical products.
Harga Saham
$0.00158262
Terakhir disinkronkan: 2026-08-17
Kapitalisasi Pasar
$10.20M
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
-
Negara
SG
Perdagangan Clearbridge Health Limited (1H3)

Kategori

Laba untuk Clearbridge Health Limited (1H3)
Laba pada 2026 TTM: 0
Menurut laporan keuangan terbaru dari Clearbridge Health Limited, laba saat ini perusahaan adalah 0. Pada tahun 2026, perusahaan memperoleh laba sebesar 0, sama dengan laba tahun 2026 sebesar 0. Laba yang ditampilkan di halaman ini adalah laba sebelum bunga dan pajak, atau disebut juga EBIT.
Riwayat laba untuk Clearbridge Health Limited dari 2026 hingga 2026
Laba pada akhir setiap tahun
Tahun Laba Mengubah
Tidak cukup data untuk tanggal yang disediakan.
Laba untuk perusahaan serupa atau pesaing
Perusahaan Laba Perbedaan Laba Negara
$7.61B -
US
$4.76B -
US
- -
CN
$-252.70M -
US
$1.42B -
US